Phospholipase C‐β1 potentiates glucose‐stimulated insulin secretion

Hyeon‐Jeong Hwang(Ulsan National Institute of Science and Technology), Pann‐Ghill Suh(Korea Brain Research Institute), Lucio Cocco(University of Bologna), Hyun‐Jun Jang(Pohang University of Science and Technology), Young Chan Chae(Ulsan National Institute of Science and Technology), Hye Yun Kim(Ulsan National Institute of Science and Technology), Masahiro Yamamoto(Kumamoto University), Per‐Olof Berggren(Karolinska Institutet), Kyoung‐Su Park(Ulsan National Institute of Science and Technology), Jaeyoon Kim(LG (United States)), Ho Lee(National Cancer Center), Yong Ryoul Yang(Korea Research Institute of Bioscience and Biotechnology), Yoon Ji Choi(Ulsan National Institute of Science and Technology), Ji Su(The University of Osaka), Jang Hyun Choi(Korea Advanced Institute of Science and Technology)
The FASEB Journal
July 3, 2019
10.1096/fj.201802732rr
Cited by 20

Related Papers

Anti-diabetic drugs inhibit obesity-linked phosphorylation of PPARγ by Cdk5
|Nature|2010|884
Roles of the Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR pathways in controlling growth and sensitivity to therapy-implications for cancer and aging
|Aging|2011|707
Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR Inhibitors: Rationale and Importance to Inhibiting These Pathways in Human Health
|Oncotarget|2011|579
GSK-3 as potential target for therapeutic intervention in cancer
|Oncotarget|2014|508
Glucose-inhibition of glucagon secretion involves activation of GABAA-receptor chloride channels
|Nature|1989|463